Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-48

  1. 2,798 Posts.
    lightbulb Created with Sketch. 547
    The possibility of the US Military running human trials is indeed very interesting. Without wanting to put a dampener on things- whatever its issues I think IMC has a lot of potential- I’m going to make two assertions. Feel free to disagree or argue against them.

    - Fast Track designation doesn’t make much difference (it still seems to take months to get an FDA appointment). Of course I’d much rather have FT than not. (god knows how bad Slow Track designation must be)

    - Involvement with the U.S. Military doesn not necessarily mean things will go quickly (or properly) either. However, I’d much rather have them on board than not.

    I know that sounds negative, I will say I am open to the suggestion that we could all be pleasantly surprised by unexpected good news. The lack of issue with safety does mean that they can jump straight to efficacy.

    They also promised the next trial data by the end of this quarter. So I’m expecting that by EOFY we’ll all get a much better feel for what direction things are going.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.6¢
Change
-0.010(13.2%)
Mkt cap ! $15.53M
Open High Low Value Volume
7.2¢ 7.2¢ 6.6¢ $62.86K 903.9K

Buyers (Bids)

No. Vol. Price($)
3 69464 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 7142 1
View Market Depth
Last trade - 16.10pm 21/07/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.